Targeted Degraders

Induce target degradation with precision and potency

Submit a project inquiry

Comprehensive services to support all steps of degrader discovery and development

Targeted Protein Degradation is a powerful strategy that leverages endogenous cellular machineries to induce the specific degradation of a protein of interest (often via leveraging E3 ubiquitin ligase complexes and their target recognition subunits, such as CRBN or VHL). We offer a range of services to support degrader discovery and development, from the early stages of target selection through screening and preclinical characterization. By coupling our powerful high-throughput screening services with deep proteomic insights, we enable the efficient discovery and development of these potent therapeutics.

  • Identify suitable degrader targets based on high-quality turnover data across >50 cell types and murine tissues
  • Leverage high-throughput screening to efficiently discover candidate ligands
  • Follow up with proteome-wide analyses to confirm target degradation, identify off-targets, measure target ubiquitination, demonstrate ternary complex formation and evaluate the downstream effects of treatment

Explore Other Modalities

We offer support for the development of a broad range of therapeutic modalities.

  • Covalent Drugs

    Unlock potent and selective therapeutics through covalent binding

  • DNA- and RNA-Targeting Drugs

    Accelerate the development of DNA- and RNA-targeted small-molecule therapeutics

  • Oligonucleotide Therapeutics

    Modulate protein expression and splicing with RNA-binding ASOs and RNAi

  • Kinase Inhibitors

    Develop selective and potent protein kinase inhibitors

  • ADCs

    Targeted immunotherapeutics for cancer treatment and beyond

  • Gene Therapies

    Modify genetic content and expression to enable new frontiers of disease treatment

  • Cell Therapies

    Harness the power of cell therapy to overcome unmet disease challenges

  • Radiotherapeutics

    Harness the ultra-sensitive analytic power of ICP-MS for radioligand discovery and development

  • Molecular Glues

    Induce or stabilize protein-protein interactions for therapeutic applications

Submit a Project Inquiry

To connect with our scientific team, submit a project inquiry. Our team will be in touch shortly to schedule an introductory meeting.

Newsletter Signup

Sign up for News & Updates